Balanced news tone
News Sentiment
SHC sentiment intelligence
Sotera Health Co news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
75/100 classification confidence.
directly relevant articles
high-authority source matches
+2.7% over one week, +13.8% over four weeks, trend inactive, and materially above fair value.
Statutory Profit Doesn't Reflect How Good Sotera Health's (NASDAQ:SHC) Earnings Are
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Statutory Profit Doesn't Reflect How Good Sotera Health's (NASDAQ:SHC) Earnings Are
The article discusses how Sotera Health's statutory profit may not fully represent the underlying strength of its earnings. It suggests looking beyond the reported figures to understand the company's financial health.
- Tone
- Positive 71/100
- Event
- Earnings
- Published
- 12 Jul 2026 10:10
- Source
- 富途牛牛
Sotera Health Co (SHC) Stock Up 5.2% but GF Value Says Overvalued -- GF Score: 74/100
Sotera Health Co (SHC) shares rose 5.2% to $18.39, but GuruFocus' GF Value indicates the stock is 12.5% overvalued compared to its intrinsic value of $16.34. Despite a solid GF Score of 74/100, concerns arise from its weak financial strength (4/10) and significant insider selling
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 09 Jul 2026 23:41
- Source
- GuruFocus
RBC Capital Maintains Sotera Health Company(SHC.US) With Buy Rating, Maintains Target Price $24
RBC Capital has reiterated its Buy rating for Sotera Health Company (SHC.US), maintaining a target price of $24. This indicates a continued positive outlook from the firm regarding Sotera Health's stock performance.
- Tone
- Positive 71/100
- Event
- Analyst action
- Published
- 09 Jul 2026 09:40
- Source
- Moomoo
How Investors Are Reacting To Sotera Health (SHC) Being Dropped From Key Russell Growth Indices
Sotera Health (SHC) was recently removed from several significant Russell growth indices in late June 2026, which may influence investor perception and trading behavior. While this change doesn't directly alter the company's core business, it interacts with its recent financing a
- Tone
- Negative 38/100
- Event
- Market update
- Published
- 08 Jul 2026 22:10
- Source
- Simply Wall Street
3 Reasons SHC is Risky and 1 Stock to Buy Instead
Sotera Health Company (SHC) is viewed as risky due to slow organic growth, limited distribution channels, and a dropping free cash flow margin. The stock has underperformed the S&P 500, losing 4.7% over the past six months while the S&P 500 gained 8%. Analysts suggest looking int
- Tone
- Negative 18/100
- Event
- Earnings
- Published
- 07 Jul 2026 22:11
- Source
- The Globe and Mail
Qiagen N.V. highlights molecular diagnostics growth as investors eye global health demand
- Tone
- Positive 66/100
- Event
- Macro sensitivity
- Published
- 06 Jul 2026 06:41
- Source
- Ad-hoc-news.de
Price to book forward of Sotera Health Company – NASDAQ:SHC
This article provides access to the "Price to book forward" financial metric for Sotera Health Company (SHC) on the Nasdaq stock market via TradingView. It indicates that the market was closed at the time of viewing and that there were no recent trades. The content primarily serv
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Jul 2026 02:39
- Source
- TradingView
Price to earnings forward of Sotera Health Company – NASDAQ:SHC
The article presents financial data for Sotera Health Company (NASDAQ: SHC), specifically focusing on its Price to Earnings (P/E) forward ratio. The content is primarily a data display page from TradingView, offering an overview of the company's financials without detailed analys
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 Jul 2026 13:10
- Source
- TradingView
1 Profitable Stock Worth Your Attention and 2 We Brush Off
This article identifies one profitable stock to buy and two to potentially avoid, based on StockStory's analysis of financial strength and long-term sustainability. TransDigm (TDG) is recommended due to strong organic growth and free cash flow, while Sotera Health (SHC) and Atmus
- Tone
- Negative 28/100
- Event
- Balance sheet
- Published
- 03 Jul 2026 09:40
- Source
- StockStory
Sotera Health (SHC) Could Be 12% Undervalued As Russell Index Removal Stirs Volatility
Sotera Health (SHC) has been removed from several Russell growth indexes, causing potential short-term volatility, yet the stock is considered 12% undervalued based on a modeled fair value of $20.22 against its current trading price of $17.75. The company's proactive compliance w
- Tone
- Positive 63/100
- Event
- Market update
- Published
- 01 Jul 2026 11:09
- Source
- Simply Wall Street
Sotera Health stock edges higher. MarketBeat highlights extended-hours gains
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 30 Jun 2026 13:34
- Source
- Ad-hoc-news.de
Price to sales forward of Sotera Health Company – NASDAQ:SHC
This article provides a brief financial overview of Sotera Health Company (NASDAQ: SHC), specifically focusing on its price-to-sales forward metric. It indicates that the company's financial data on this metric is available for different periods and values, emphasizing its availa
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 30 Jun 2026 05:40
- Source
- TradingView
Does Sotera Health's (SHC) Russell Index Exit Quietly Reshape Its Long-Term Investor Base Narrative?
Sotera Health (SHC) was removed from several Russell growth indices on June 27, 2026, which could alter its shareholder base and trading profile. This index exclusion affects who owns the stock rather than its operational fundamentals, with near-term catalysts and long-term risks
- Tone
- Negative 40/100
- Event
- Market update
- Published
- 29 Jun 2026 09:11
- Source
- Simply Wall Street
Is Sotera Health Company (SHC) A Good Stock To Buy Now?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 29 Jun 2026 07:00
- Source
- Market source
Sotera Health Company(NasdaqGS: SHC) dropped from Russell 2500 Growth Benchmark
Sotera Health Company (NasdaqGS:SHC) has been removed from the Russell 2500 Growth Benchmark. The article provides a company profile outlining its services in sterilization and lab testing, along with recent news including lock-up agreements, conference presentations, and Q1 2026
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jun 2026 06:09
- Source
- marketscreener.com
Enterprise value to revenue forward of Sotera Health Company – NASDAQ:SHC
This article provides financial data for Sotera Health Company (NASDAQ: SHC), specifically focusing on its enterprise value to revenue forward. It appears to be a snapshot from a financial analysis platform like TradingView, detailing various financial metrics and market informat
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 28 Jun 2026 08:40
- Source
- TradingView
Sotera Health shares, sector peers and risk management in focus
Sotera Health (SHC) shares, listed on NASDAQ, specialize in health services for medical device and pharmaceutical manufacturers, focusing on sterilization and lab testing. The company's business model, which includes Sterigenics, Nordion, and Nelson Labs, provides risk-management
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Jun 2026 19:40
- Source
- Ad-hoc-news.de
Sotera Health Company Actuals & Estimates (NASDAQ:SHC)
This article provides an overview of Sotera Health Company (NASDAQ: SHC) stock, including its current price, historical performance, and analyst forecasts. It also details financial metrics such as market capitalization, earnings per share, revenue, and EBITDA, along with informa
- Tone
- Positive 64/100
- Event
- Earnings
- Published
- 26 Jun 2026 16:09
- Source
- TradingView
Sotera Shareholder Action Reminder
Faruqi & Faruqi, LLP reminds investors of the March 27, 2023 deadline to seek the role of lead plaintiff in a federal securities class action filed against Sotera Health Company (NASDAQ: SHC). The lawsuit alleges that Sotera made false and misleading representations regarding its
- Tone
- Negative 14/100
- Event
- Regulatory and legal
- Published
- 26 Jun 2026 03:40
- Source
- TMX Newsfile
3 Promising Stocks Trading 25.2% to 33.7% Below Intrinsic Value Estimates
Amidst a fluctuating U.S. market, three stocks—Sotera Health (SHC), American Healthcare REIT (AHR), and Toast (TOST)—are identified as trading significantly below their intrinsic value estimates. These companies show promising long-term growth potential and strong earnings foreca
- Tone
- Positive 73/100
- Event
- Earnings
- Published
- 25 Jun 2026 16:09
- Source
- Simply Wall Street
Sotera Health Is Maintained at Overweight by Barclays
Barclays has reiterated its 'Overweight' rating on Sotera Health (SHC) stock. This indicates the firm's positive outlook on the company's performance. The detailed analyst report likely provides further insights into this decision.
- Tone
- Positive 70/100
- Event
- Analyst action
- Published
- 24 Jun 2026 16:10
- Source
- Moomoo
Barclays Maintains Sotera Health Company(SHC.US) With Buy Rating, Raises Target Price to $19
Barclays has reiterated its Buy rating on Sotera Health Company (SHC.US) and increased its price target from $17 to $19. This adjustment reflects the analyst's updated valuation for the company.
- Tone
- Positive 76/100
- Event
- Analyst action
- Published
- 24 Jun 2026 08:40
- Source
- Moomoo
Should Surging Institutional Ownership and Profitability Gains Require Action From Sotera Health (SHC) Investors?
Sotera Health recently reported improved quarterly revenue and a significant year-over-year jump in net profit, ranking 23rd among healthcare peers. Concurrently, institutional investors now hold almost 94.60% of Sotera’s shares, reflecting a sharp increase and major position cha
- Tone
- Positive 67/100
- Event
- Earnings
- Published
- 20 Jun 2026 05:09
- Source
- Simply Wall Street
Sotera Health Co (SHC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution
Sotera Health Co (SHC) revenue breakdown data indicates that as of the most recent disclosure, the United States accounted for 54.10% of its revenue, totaling $629.54 million. Following the U.S., Europe contributed 19.95% ($232.18 million) and Canada contributed 19.07% ($221.95 m
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 Jun 2026 10:10
- Source
- TradingKey
1 Healthcare Stock for Long-Term Investors and 2 We Turn Down
This article evaluates three healthcare stocks, recommending one for long-term investment while advising against two others. Natera (NTRA) is highlighted as a strong buy due to elevated product demand, rising operating profits, and positive free cash flow. In contrast, Sotera Hea
- Tone
- Negative 31/100
- Event
- Balance sheet
- Published
- 17 Jun 2026 00:09
- Source
- The Globe and Mail
Sotera Health Co Stock (US8293551086): Earnings Metrics In Focus After Recent Quarterly Update
This article focuses on how investors are evaluating Sotera Health Co (SHC) after its latest quarterly earnings report. Key metrics such as revenue trends, margin dynamics, cash flow, and balance sheet signals are being scrutinized to assess the company's performance, financial h
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 16 Jun 2026 20:38
- Source
- AD HOC NEWS
Certain Stock Options of Sotera Health Company are subject to a Lock-Up Agreement Ending on 11-JUN-2026.
Certain stock options of Sotera Health Company (SHC) are under a 31-day lock-up agreement, preventing executive officers, directors, and selling stockholders from trading them. This lock-up period began on May 11, 2026, and concludes on June 11, 2026. The agreement is in place to
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 Jun 2026 00:10
- Source
- www.marketscreener.com
Sotera Health (SHC) Valuation After Goldman Coverage Legal Clarity And Earnings Beat
Sotera Health (SHC) is gaining momentum following Goldman Sachs' initiation of coverage, a strong Q1 2026 earnings beat, and clarity on Ethylene Oxide legal issues. The stock is currently trading at US$16.53, with analysts suggesting an intrinsic discount and upside to targets. W
- Tone
- Positive 71/100
- Event
- Earnings
- Published
- 10 Jun 2026 21:39
- Source
- Simply Wall Street
Sotera Health Company (SHC) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary
Sotera Health Company (SHC) recently participated in the Goldman Sachs 47th Annual Global Healthcare Conference 2026, where they outlined a planned CEO transition for 2026 and a strategic planning initiative for long-term growth. The company reported robust Q1 performance with 6.
- Tone
- Positive 71/100
- Event
- Market update
- Published
- 10 Jun 2026 11:40
- Source
- Quartr
Geode Capital Management LLC Acquires 476,365 Shares of Sotera Health Company $SHC
Geode Capital Management LLC has increased its stake in Sotera Health Company (NASDAQ:SHC) by 13.8%, purchasing an additional 476,365 shares. This acquisition brings their total holdings to 3.93 million shares valued at approximately $69.4 million. Sotera Health recently reported
- Tone
- Positive 67/100
- Event
- Deals and strategy
- Published
- 09 Jun 2026 09:39
- Source
- MarketBeat